A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase

被引：70

作者：

Cheng, Hsueh-Ling ^{[1
]}

Huang, Hsin-Kai ^{[1
]}

Chang, Chi-I ^{[1
]}

Tsai, Chung-Pao ^{[1
]}

Chou, Chang-Hung ^{[2
]}

机构：

[1] Natl Pingtung Univ Sci & Technol, Grad Inst Biotechnol, Pingtung 91201, Taiwan

[2] China Med Univ, Res Ctr Biodivers, Taichung 40402, Taiwan

来源：

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY | 2008年 / 56卷 / 16期

关键词：

insulin resistance; Momordica charantia; FL83B cells; triterpenoids; screening; AMP-activated protein kinase;

D O I：

10.1021/jf800801k

中图分类号：

S [农业科学];

学科分类号：

09 ;

摘要：

Treatment of insulin resistance is a critical strategy in the prevention and management of type 2 diabetes. The crude extracts from all parts of Momordica charantia L. have been reported by many studies for the effective treatment of diabetes and related complications. However, the exact ingredients responsible for the hypoglycemic effect and the underlying mechanism of their actions have not been well characterized because of the lack of a proper assay and screening system. A new cell-based, nonradioactive, and nonfluorescent screening method was demonstrated in this study to screen for natural products from the stem of M. charantia, aiming to identify hypoglycemic components that can overcome cellular insulin resistance. The results suggest triterpenoids being potential hypoglycemic components of the plant and the mechanism underlying their action involving AMP-activated protein kinase.

引用

页码：6835 / 6843

页数：9

共 30 条

[21] Treatment of insulin resistance in diabetes mellitus [J].

Lebovitz, HE ;

Banerji, MA .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 490 (1-3) :135-146

[22] AMP-activated protein kinase signaling in metabolic regulation [J].

Long, Yun Chau ;

Zierath, Juleen R. .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (07) :1776-1783

[23]

Matsuda H, 1998, CHEM PHARM BULL, V46, P1399, DOI 10.1248/cpb.46.1399

[24] Does bitter melon contain an activator of AMP-activated kinase? [J].

McCarty, MF .

MEDICAL HYPOTHESES, 2004, 63 (02) :340-343

[25]

Miura T, 2001, J NUTR SCI VITAMINOL, V47, P340, DOI 10.3177/jnsv.47.340

[26] Peroxisome proliferator-activated receptor γ in diabetes and metabolism [J].

Rangwala, SM ;

Lazar, MA .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (06) :331-336

[27] Anti-diabetic potentials of Momordica charantia and Andrographis paniculata and their effects on estrous cyclicity of alloxan-induced diabetic rats [J].

Reyes, BAS ;

Bautistac, ND ;

Tanquilut, NC ;

Anunciado, RV ;

Leung, AB ;

Sanchez, GC ;

Magtoto, RL ;

Castronuevo, P ;

Tsukamura, H ;

Maeda, KI .

JOURNAL OF ETHNOPHARMACOLOGY, 2006, 105 (1-2) :196-200

[28] Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes [J].

Sarkar, S ;

Pranava, M ;

Marita, R .

PHARMACOLOGICAL RESEARCH, 1996, 33 (01) :1-4

[29] A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli [J].

Yoshioka, K ;

Takahashi, H ;

Homma, T ;

Saito, M ;

Oh, KB ;

Nemoto, Y ;

Matsuoka, H .

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1996, 1289 (01) :5-9

[30] Insulin can enhance GLUT4 gene expression in 3T3-F442A cells and this effect is mimicked by vanadate but counteracted by cAMP and high glucose -: potential implications for insulin resistance [J].

Zhi-Wen, Y ;

Burén, J ;

Enerbäck, S ;

Nilsson, E ;

Samuelsson, L ;

Eriksson, JW .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2001, 1535 (02) :174-185

← 1 2 3 →